Looking to expand your partner network with leading companies like Rigontec? Consider joining Inpart's global network for free.
Interview 29 Jan 2018
Meet the CEO of the Other Big Biotech Acquisition Target in 2017
Christian Schetter’s company, Rigontec, was acquired by MSD last year for nearly half a billion euro. How did he and the company do it, with only one early-stage candidate? There were exactly two notable biotech acquisitions in Europe last year: Actelion and a smaller startup based in Munich called Rigontec, which had an RNA candidate […]
